#METABOLOMICS WORKBENCH beyondcpu_20180625_083329 DATATRACK_ID:1429 STUDY_ID:ST000994 ANALYSIS_ID:AN001623 PROJECT_ID:PR000674
VERSION             	1
CREATED_ON             	June 29, 2018, 12:45 pm
#PROJECT
PR:PROJECT_TITLE                 	SWGNP
PR:PROJECT_SUMMARY               	SWGNP protect rats from CCl4 induced liver fibrosis
PR:INSTITUTE                     	Nanjing University of Science & Technology
PR:LAST_NAME                     	Li
PR:FIRST_NAME                    	Minghui
PR:ADDRESS                       	200 Xiaolingwei Str., Nanjing, Jiangsu, 210094, China
PR:EMAIL                         	cpu_lmh@126.com
PR:PHONE                         	+8615952052370
#STUDY
ST:STUDY_TITLE                   	Tibetan medicine Shi-Wei-Gan-Ning-Pill (SWGNP) protect rats from ccl4 induced
ST:STUDY_TITLE                   	liver fibrosis (Part II: Serum)
ST:STUDY_SUMMARY                 	SWGNP protect rats from CCl4 induced liver fibrosis
ST:INSTITUTE                     	Nanjing University of Science & Technology
ST:LAST_NAME                     	Li
ST:FIRST_NAME                    	Minghui
ST:ADDRESS                       	200 Xiaolingwei Str., Nanjing, Jiangsu, 210094, China
ST:EMAIL                         	cpu_lmh@126.com
ST:PHONE                         	+8615952052370
#SUBJECT
SU:SUBJECT_TYPE                  	Other
SU:SUBJECT_SPECIES               	Rattus norvegicus
SU:TAXONOMY_ID                   	10116
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	-	K213	Treatment:Control	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	K216	Treatment:Control	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	K225	Treatment:Control	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	K234	Treatment:Control	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	K239	Treatment:Control	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	K253	Treatment:Control	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	K257	Treatment:Control	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	K433	Treatment:Control	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	K442	Treatment:Control	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	K447	Treatment:Control	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	M202	Treatment:Model	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	M203	Treatment:Model	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	M207	Treatment:Model	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	M211	Treatment:Model	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	M214	Treatment:Model	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	M217	Treatment:Model	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	M226	Treatment:Model	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	M240	Treatment:Model	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	M251	Treatment:Model	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	M443	Treatment:Model	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	A206	Treatment:Low	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	A232	Treatment:Low	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	A241	Treatment:Low	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	A242	Treatment:Low	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	A252	Treatment:Low	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	A254	Treatment:Low	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	A255	Treatment:Low	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	A258	Treatment:Low	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	A259	Treatment:Low	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	A268	Treatment:Low	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	B236	Treatment:Medium	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	B256	Treatment:Medium	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	B263	Treatment:Medium	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	B264	Treatment:Medium	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	B269	Treatment:Medium	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	B277	Treatment:Medium	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	B279	Treatment:Medium	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	B280	Treatment:Medium	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	B281	Treatment:Medium	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	B434	Treatment:Medium	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	C238	Treatment:High	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	C276	Treatment:High	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	C286	Treatment:High	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	C287	Treatment:High	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	C288	Treatment:High	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	C290	Treatment:High	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	C292	Treatment:High	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	C297	Treatment:High	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	C430	Treatment:High	Tissue=Serum
SUBJECT_SAMPLE_FACTORS           	-	C436	Treatment:High	Tissue=Serum
#COLLECTION
CO:COLLECTION_SUMMARY            	Serum
CO:SAMPLE_TYPE                   	Blood (serum)
#TREATMENT
TR:TREATMENT_SUMMARY             	Rats were treated with low, medium and high dose of SWGNP
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Serum were deproteinized by adding 1 mL methanol
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	-
CH:INSTRUMENT_NAME               	-
CH:COLUMN_NAME                   	-
#ANALYSIS
AN:ANALYSIS_TYPE                 	NMR
#NMR
NM:INSTRUMENT_NAME               	Bruker
NM:INSTRUMENT_TYPE               	FT-NMR
NM:NMR_EXPERIMENT_TYPE           	1D-1H
NM:SPECTROMETER_FREQUENCY        	500 MHz
NM:NMR_RESULTS_FILE              	ST000994_AN001623_Results.txt	UNITS:intensity
#END